Argent Trust CO Novo Nordisk A S Transaction History

Argent Trust CO

$2.4 Billion
Q4 2024

A detailed history of Argent Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Argent Trust CO holds 8,240 shares of NVO stock, worth $544,334. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,240

Previous 9,752 15.5%

Holding current value

$544,334

Previous $1.16 Million 39.02%

% of portfolio

0.03%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$85.0 - $120.04 $128,520 - $181,500	-1,512 Reduced 15.5%	8,240 $708,000
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $94,541 - $115,463	794 Added 8.86%	9,752 $1.16 Million
Q2 2024 Aug 12, 2024	BUY	$122.71 - $146.91 $223,823 - $267,963	1,824 Added 25.57%	8,958 $1.28 Million
Q1 2024 May 10, 2024	SELL	$102.11 - $135.92 $13,682 - $18,213	-134 Reduced 1.84%	7,134 $916,000
Q4 2023 Feb 09, 2024	SELL	$87.78 - $105.45 $29,318 - $35,220	-334 Reduced 4.39%	7,268 $751,000
Q3 2023 Nov 08, 2023	BUY	$90.94 - $199.54 $326,838 - $717,146	3,594 Added 89.67%	7,602 $691,000
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $135,648 - $163,118	-1,025 Reduced 20.37%	4,008 $637,000
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $476 - $584	-5 Reduced 0.1%	5,033 $502,000
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $7,330 - $8,648	71 Added 1.43%	5,038 $562,000
Q3 2021 Nov 09, 2021	BUY	$84.42 - $106.62 $5,402 - $6,823	64 Added 1.31%	4,967 $477,000
Q2 2021 Aug 09, 2021	BUY	$67.66 - $84.76 $25,237 - $31,615	373 Added 8.23%	4,903 $411,000
Q1 2021 May 12, 2021	SELL	$67.06 - $75.82 $7,913 - $8,946	-118 Reduced 2.54%	4,530 $305,000
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $296,960 - $343,022	4,648 New	4,648 $325,000

Others Institutions Holding NVO

# of Institutions

1,882

Shares Held

337M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $149B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account